MED•benzinga•
UPDATE: Medifast Raises FY22 Guidance: Sales From $1.72B-$1.79B To $1.78B-$1.84B vs $1.77B Estimate, EPS From $14.50-$16 To $14.60-$16.05 vs $15.62 Est.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 2, 2022 by benzinga